This is a $1,874.80 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4565597417 - Ketorolac 30 MG/ML Vial. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which provides a comprehensive range of medical commodities to support...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, for the supply of 4563635141 - Ketorolac 60 mg/2 ml vial 2 ml. The contract has a potential value of $1,275.88 and a completion date of February 13, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania, is the prime contractor on this delivery order. This award is part of a...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Ketorolac 30 mg/ml vials. The contract has a ceiling value of $16,221.75 and a period of performance through December 22, 2023. It is a delivery order contract with a firm fixed price pricing type. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a defense agency. The contract is a delivery order valued at $2,909.40 with a firm fixed price and an ultimate completion date of June 11, 2025. The contract is for the supply of KETOROLAC 30 MG/ML VIALML, a pharmaceutical product, and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a defense agency. The contract is for the delivery of Ketorolac 30 mg/ml vials, a prescription medication. The contract has a ceiling value of $1,326.96 and is a firm-fixed-price delivery order with a completion date of May 28, 2025. The contract is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a substantial Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of Ketorolac 30 mg/ml vial, a pharmaceutical product. The contract has a ceiling value of $1,588.62 and is a Firm Fixed Price Delivery Order with an ultimate completion date of April 9, 2025. The contract is not associated with any set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a significant...
This federal contract award, valued at $1,511.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ketorolac 30 mg/ml vial, a pain management medication. This is a Firm Fixed Price Delivery Order contract with an ultimate completion date of April 16, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of Ketorolac 30 mg/ml vials, a prescription pain medication. The $1,209.90 Firm Fixed Price Delivery Order was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of July 8, 2024. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical through...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of Ketorolac 30 mg/mL vials. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $1,124.88. The contract has an ultimate completion date of September 25, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to $999,999,999 and...
This federal contract award is for the delivery of ketorolac 60 mg/2 ml vials to the Defense Logistics Agency (DLA), a defense agency under the Department of Defense (DoD). The contract, valued at $2,007.79, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on June 10, 2024. The contract has a performance period ending on June 11, 2024 and is a Firm Fixed Price Delivery Order. The award is part of a larger Indefinite Delivery Contract (IDC) held by...